Prognosis of hepatocellular carcinoma expressing cytokeratin 19: Comparison with other liver cancers

doi:10.3748/wjg.v18.i34.4751

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 34

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5829)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

522

HTML

4839

Figures (1-2)

288

Tables (1-2)

180

Sum=5829

Sep 14, 2012 (publication date) through Sep 19, 2024

Times Cited of This Article

Times Cited (56)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 14, 2012; 18(34): 4751-4757
Published online Sep 14, 2012. doi: 10.3748/wjg.v18.i34.4751

Full Size Figure Download Figure

Figure 1 Pathological features of primary liver cancer. A-D: Hematoxylin and eosin (HE) stain for cytokeratin 19 negative hepatocellular carcinoma (CK19^- HCC) (A), cytokeratin 19 positive hepatocellular carcinoma (CK19⁺ HCC) (B), combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) and intrahepatic cholangiocarcinoma (ICC); E-H: Immunohistochemical stain results of CK19 stain for CK19^- HCC (E), CK19⁺ HCC (F), cHCC-CC (G) and ICC (H). All in original magnification × 200.

Citation: Lee JI, Lee JW, Kim JM, Kim JK, Chung HJ, Kim YS. Prognosis of hepatocellular carcinoma expressing cytokeratin 19: Comparison with other liver cancers. World J Gastroenterol 2012; 18(34): 4751-4757
URL: https://www.wjgnet.com/1007-9327/full/v18/i34/4751.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i34.4751